Protocol No.: D9103C00001

Title
A Phase III, Randomized, Placebo-Controlled, Double-Blind, Multicenter, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with Stage I/II Non-small Cell Lung Cancer
Principal Investigator
Almubarak, Mohammed
Phase
III
Age Group
Adult
Applicable Disease Site
Lung Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Carla Ross, RN
Senior Research Nurse
Phone: +1 304-293-2633

View on ClinicalTrials.gov